Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 1 EP application Mirna Atallah has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16756939

NOVEL DOSAGE REGIMEN TIACUMICIN COMPOUND

IPC classification:
A61P 1/12, A61P 31/04, A61K 31/7048
Agent:
Mirna Atallah, Astellas Pharma Europe BV
Status:
Request for examination was made

Please Sign in to use this feature